The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback